TQA3526

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQA3526, covering 2020-02-20 to 2020-02-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TQA3526 in the Treatment of Primary Biliary Cirrhosis (PBC) [Phase 2]